Literature DB >> 21764587

Charcot-Marie-Tooth disease associated with recurrent optic neuritis.

Benjamin R Wakerley1, Francesca E Harman, Daniel M Altmann, Omar Malik.   

Abstract

The factors precipitating central nervous system (CNS) demyelination, including optic neuritis, remain largely unknown but are likely to represent a complex interplay between the patient's environment and their genetic background. We report the development of sequential demyelinating optic neuritis in a patient with genetically confirmed Charcot-Marie-Tooth disease type 1A, a hereditary neuropathy. This neuropathy is characterized by duplication of peripheral myelin protein 22 (PMP22), which results in structurally abnormal peripheral myelin. By characterizing peripheral T-cell responses in this patient to a panel of myelin epitopes expressed in the CNS we describe an immunological process which indicates that overexpression of PMP22 may be causative and account for this association.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21764587     DOI: 10.1016/j.jocn.2011.03.003

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  3 in total

1.  Occurrence of Optic Neuritis and Cervical Cord Schwannoma with Charcot-Marie-Tooth Type 4B1 Disease.

Authors:  Patrick Scott; Zandre Bruwer; Khalsa Al-Kharusi; Douja Meftah; Fathiya Al-Murshedi
Journal:  Oman Med J       Date:  2016-05

2.  Aquaporin-4-antibody-positive Neuromyelitis Optica Spectrum Disorder in a Patient with Charcot-Marie-Tooth Disease Type 1A.

Authors:  Yuichi Hamada; Kazusa Takahashi; Takamichi Kanbayashi; Yuki Hatanaka; Shunsuke Kobayashi; Masahiro Sonoo
Journal:  Intern Med       Date:  2020-12-22       Impact factor: 1.271

3.  Central Nervous System Demyelination in a Charcot-Marie-Tooth Type 1A Patient.

Authors:  Christos Koros; Maria-Eleftheria Evangelopoulos; Costas Kilidireas; Elisabeth Andreadou
Journal:  Case Rep Neurol Med       Date:  2013-12-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.